Robert L Coleman Selected Research

Robert L Coleman Research Topics

Disease

185	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 01/2002
179	Neoplasms (Cancer) 04/2024 - 01/2002
70	Carcinoma (Carcinomatosis) 04/2024 - 01/2002
42	Endometrial Neoplasms (Endometrial Cancer) 04/2024 - 01/2007
42	Ovarian Epithelial Carcinoma 01/2023 - 01/2002
24	Disease Progression 01/2024 - 07/2008
24	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2023 - 02/2002
11	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2006
10	Neutropenia 01/2023 - 04/2006
8	Nausea 04/2024 - 01/2008
8	Uterine Neoplasms (Uterine Cancer) 05/2023 - 05/2009
8	Fatigue 01/2023 - 01/2008
8	Adenocarcinoma 01/2022 - 03/2004
8	Fallopian Tube Neoplasms 12/2021 - 12/2006
7	Anemia 12/2022 - 11/2015
6	Breast Neoplasms (Breast Cancer) 01/2023 - 03/2009
6	Hypertension (High Blood Pressure) 01/2022 - 11/2011
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 03/2002
5	Hypoxia (Hypoxemia) 02/2018 - 11/2011
4	Vomiting 04/2024 - 01/2008
4	Thrombocytopenia (Thrombopenia) 01/2023 - 05/2011
4	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2020
4	Vulvar Neoplasms (Vulvar Cancer) 04/2020 - 11/2012
4	Ascites 10/2016 - 01/2011
3	Exanthema (Rash) 01/2022 - 04/2006
3	Granulosa Cell Tumor 04/2020 - 09/2009

Drug/Important Bio-Agent (IBA)

84	PlatinumIBA 04/2024 - 01/2002
40	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2002
38	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2024 - 06/2015
31	Biomarkers (Surrogate Marker)IBA 04/2024 - 03/2004
29	Bevacizumab (Avastin)FDA Link 11/2023 - 12/2007
26	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 01/2002
24	rucaparibIBA 01/2023 - 06/2016
22	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 08/2006
17	taxaneIBA 11/2017 - 01/2002
16	Docetaxel (Taxotere)FDA Link 01/2016 - 08/2006
15	liposomal doxorubicin (Doxil)FDA Link 01/2023 - 08/2004
13	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2008
13	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2022 - 07/2013
13	Topotecan (Hycamtin)FDA LinkGeneric 11/2020 - 01/2002
12	Small Interfering RNA (siRNA)IBA 01/2022 - 08/2006
11	Immunoconjugates (Immunoconjugate)IBA 05/2023 - 09/2009
10	olaparibIBA 03/2022 - 11/2018
9	Monoclonal AntibodiesIBA 01/2023 - 09/2009
8	1-dodecylpyridoxal (PLD)IBA 11/2021 - 10/2006
7	niraparibIBA 11/2023 - 11/2018
7	Poly Adenosine Diphosphate RiboseIBA 01/2023 - 01/2020
7	veliparibIBA 01/2023 - 06/2015
7	Progesterone Receptors (Progesterone Receptor)IBA 04/2020 - 06/2009
7	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2002
6	pembrolizumabIBA 04/2024 - 01/2018
6	AntigensIBA 12/2023 - 07/2016
6	tisotumab vedotinIBA 05/2023 - 01/2020
6	farletuzumabIBA 01/2023 - 03/2010
6	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023 - 06/2013
6	Folate Receptor 1IBA 01/2023 - 03/2010
6	Estrogen ReceptorsIBA 11/2020 - 07/2008
5	selinexorIBA 04/2024 - 12/2021
5	mirvetuximab soravtansineIBA 12/2023 - 03/2015
5	dostarlimabIBA 11/2023 - 12/2022
5	FANG vaccineIBA 02/2023 - 12/2020
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 07/2015
5	trametinibIBA 01/2022 - 01/2015
5	Letrozole (Femara)FDA LinkGeneric 01/2022 - 07/2008
5	Everolimus FDA Link 01/2022 - 12/2010
5	ErbB Receptors (EGF Receptor)IBA 11/2020 - 01/2007
5	Angiogenesis InhibitorsIBA 10/2020 - 12/2009
5	Taxoids (Taxanes)IBA 01/2020 - 08/2006
5	Focal Adhesion Protein-Tyrosine KinasesIBA 05/2019 - 08/2006
5	Gemcitabine FDA Link 01/2017 - 03/2007
5	afliberceptIBA 01/2016 - 04/2008
5	LigandsIBA 01/2016 - 02/2007
5	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2011 - 09/2006
5	1,2-oleoylphosphatidylcholine (DOPC)IBA 11/2011 - 08/2006
4	EC145IBA 01/2023 - 12/2013
4	Peptides (Polypeptides)IBA 01/2021 - 04/2014
4	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 12/2008
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2016 - 01/2007
3	Thromboplastin (Tissue Factor)IBA 01/2023 - 01/2020
3	MK 2206IBA 04/2022 - 01/2020
3	Dasatinib (BMS 354825)FDA Link 10/2021 - 04/2014
3	TrabectedinIBA 01/2021 - 01/2020
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2021 - 01/2014
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 02/2013
3	Tyrosine Kinase InhibitorsIBA 11/2020 - 07/2014
3	Hormones (Hormone)IBA 04/2020 - 06/2009

Therapy/Procedure

158	Therapeutics 04/2024 - 01/2002
94	Drug Therapy (Chemotherapy) 01/2024 - 01/2002
15	Hysterectomy 12/2022 - 02/2002
13	Neoadjuvant Therapy 01/2022 - 03/2008
12	Immunotherapy 04/2024 - 01/2015
12	Lymph Node Excision (Lymph Node Dissection) 10/2021 - 02/2002
9	Cytoreduction Surgical Procedures 01/2023 - 10/2010
5	Radiotherapy 12/2022 - 01/2005
5	Salpingo-oophorectomy 12/2022 - 03/2009
5	Combination Drug Therapy (Combination Chemotherapy) 04/2011 - 03/2007
4	Laparotomy 01/2020 - 01/2007
4	Minimally Invasive Surgical Procedures 01/2020 - 10/2010
4	Drug Tapering 01/2019 - 04/2006
3	Aftercare (After-Treatment) 11/2020 - 01/2007